Cargando…

Prevalence of integron classes in Gram-negative clinical isolated bacteria in Iran: a systematic review and meta-analysis

OBJECTIVE(S): Integrons, as a potential element in the distribution and maintenance of drug resistance, have thoroughly been established. It is known that the high prevalence of integrons in multidrug-resistant (MDR) clinical isolates has become a serious public health concern. The objective of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pormohammad, Ali, Pouriran, Ramin, Azimi, Hadi, Goudarzi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396983/
https://www.ncbi.nlm.nih.gov/pubmed/30834075
http://dx.doi.org/10.22038/ijbms.2018.32052.7697
_version_ 1783399354267074560
author Pormohammad, Ali
Pouriran, Ramin
Azimi, Hadi
Goudarzi, Mehdi
author_facet Pormohammad, Ali
Pouriran, Ramin
Azimi, Hadi
Goudarzi, Mehdi
author_sort Pormohammad, Ali
collection PubMed
description OBJECTIVE(S): Integrons, as a potential element in the distribution and maintenance of drug resistance, have thoroughly been established. It is known that the high prevalence of integrons in multidrug-resistant (MDR) clinical isolates has become a serious public health concern. The objective of the present study was to determine the frequency of different classes of integrons in clinical isolates in Iran. MATERIALS AND METHODS: Electronic global databases were systematically searched. The raw data for integrons among bacterial isolates were collected and their prevalence was analyzed using Comprehensive Meta-Analysis V2.0 (Biostat, Englewood, NJ, USA) software. RESULTS: In a comprehensive literature review, 29 eligible studies were determined with their meta-analyses indicating the prevalence of integron class 1 to be 41% (95% CI 36.3-46.1) and integron class 2 as 17.7% (95% CI 13-23.3) in Gram-negative bacteria. The highest prevalence of integron class 1 was reported in Acinetobacter spp (58%) while the highest prevalence of integron class 2 was reported in Shigella isolates (83.7%). The frequencies of class 1 integron in MDR (79%) and non-MDR isolates (41%) were higher than those for class 2 integron in MDR (13.4%) and non-MDR isolates (17.7%). CONCLUSION: The current systematic review demonstrated the significant presence of integrons among clinical isolates. Our analysis showed that measures such as estimates of the prevalence of this transposable element and diligence in continued surveillance might be necessary to prevent its spread.
format Online
Article
Text
id pubmed-6396983
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Mashhad University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-63969832019-03-04 Prevalence of integron classes in Gram-negative clinical isolated bacteria in Iran: a systematic review and meta-analysis Pormohammad, Ali Pouriran, Ramin Azimi, Hadi Goudarzi, Mehdi Iran J Basic Med Sci Review Article OBJECTIVE(S): Integrons, as a potential element in the distribution and maintenance of drug resistance, have thoroughly been established. It is known that the high prevalence of integrons in multidrug-resistant (MDR) clinical isolates has become a serious public health concern. The objective of the present study was to determine the frequency of different classes of integrons in clinical isolates in Iran. MATERIALS AND METHODS: Electronic global databases were systematically searched. The raw data for integrons among bacterial isolates were collected and their prevalence was analyzed using Comprehensive Meta-Analysis V2.0 (Biostat, Englewood, NJ, USA) software. RESULTS: In a comprehensive literature review, 29 eligible studies were determined with their meta-analyses indicating the prevalence of integron class 1 to be 41% (95% CI 36.3-46.1) and integron class 2 as 17.7% (95% CI 13-23.3) in Gram-negative bacteria. The highest prevalence of integron class 1 was reported in Acinetobacter spp (58%) while the highest prevalence of integron class 2 was reported in Shigella isolates (83.7%). The frequencies of class 1 integron in MDR (79%) and non-MDR isolates (41%) were higher than those for class 2 integron in MDR (13.4%) and non-MDR isolates (17.7%). CONCLUSION: The current systematic review demonstrated the significant presence of integrons among clinical isolates. Our analysis showed that measures such as estimates of the prevalence of this transposable element and diligence in continued surveillance might be necessary to prevent its spread. Mashhad University of Medical Sciences 2019-02 /pmc/articles/PMC6396983/ /pubmed/30834075 http://dx.doi.org/10.22038/ijbms.2018.32052.7697 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Pormohammad, Ali
Pouriran, Ramin
Azimi, Hadi
Goudarzi, Mehdi
Prevalence of integron classes in Gram-negative clinical isolated bacteria in Iran: a systematic review and meta-analysis
title Prevalence of integron classes in Gram-negative clinical isolated bacteria in Iran: a systematic review and meta-analysis
title_full Prevalence of integron classes in Gram-negative clinical isolated bacteria in Iran: a systematic review and meta-analysis
title_fullStr Prevalence of integron classes in Gram-negative clinical isolated bacteria in Iran: a systematic review and meta-analysis
title_full_unstemmed Prevalence of integron classes in Gram-negative clinical isolated bacteria in Iran: a systematic review and meta-analysis
title_short Prevalence of integron classes in Gram-negative clinical isolated bacteria in Iran: a systematic review and meta-analysis
title_sort prevalence of integron classes in gram-negative clinical isolated bacteria in iran: a systematic review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396983/
https://www.ncbi.nlm.nih.gov/pubmed/30834075
http://dx.doi.org/10.22038/ijbms.2018.32052.7697
work_keys_str_mv AT pormohammadali prevalenceofintegronclassesingramnegativeclinicalisolatedbacteriainiranasystematicreviewandmetaanalysis
AT pouriranramin prevalenceofintegronclassesingramnegativeclinicalisolatedbacteriainiranasystematicreviewandmetaanalysis
AT azimihadi prevalenceofintegronclassesingramnegativeclinicalisolatedbacteriainiranasystematicreviewandmetaanalysis
AT goudarzimehdi prevalenceofintegronclassesingramnegativeclinicalisolatedbacteriainiranasystematicreviewandmetaanalysis